NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

Validation is basically a book-keeping/administrative task to make sure that all of the modules are properly filled and that nothing in the application is missing.

And yet, you continue to insist that Northwest PR when this bookkeeping process is complete, as if it will somehow move the needle on the share price, or that it's an important detail that retail shareholders should be informed about.

The problem, IMO, is that you see this administrative event as worthy of a PR, and you've planted your flag in the ground on that point, and yet, the company doesn't see it that way. Additionally, the company doesn't want to PR what they perceive as a non-event as it may look as if they're promoting the treatment, and the MHRA doesn't approve of that type of behavior.

Remember, as well, that the company got into a bit of hot water for a Cambridge Independent article that quoted LP awhile back (a watchdog entity of some kind reported them trying to make a big deal of it) making some sort of simple comment; and then the company was also fined back in 2015 for that large Rancantour piece.

So perhaps consider giving this validation issue a bit of a rest. You're not running the company, so the decision isn't up to you as to whether this issue of "validation" is important or not. To them, it's not.

If you don't agree me on this point, may I suggest that you simply CALL the company and ask whether they think validation is the big deal you think it is?

And/or tell them why you think completing this bookkeeping process is requires a PR to state it.